UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Statistical methods in recent HIV noninferiority trials: reanalysis of 11 trials

PloS one, 2011-09, Vol.6 (9), p.e22871-e22871

2011

Volltextzugriff (PDF)

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients

PloS one, 2012-05, Vol.7 (5), p.e36673-e36673

2012

Volltextzugriff (PDF)

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study

PloS one, 2017-12, Vol.12 (12), p.e0187517-e0187517

2017

Volltextzugriff (PDF)

Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen

PloS one, 2011-09, Vol.6 (9), p.e24798

2011

Volltextzugriff (PDF)

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

PloS one, 2012-07, Vol.7 (7), p.e41390-e41390

2012

Volltextzugriff (PDF)

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

PloS one, 2015-06, Vol.10 (6), p.e0127816-e0127816

2015

Volltextzugriff (PDF)

Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set

PloS one, 2013-03, Vol.8 (3), p.e59014

2013

Volltextzugriff (PDF)

A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity

PloS one, 2013-10, Vol.8 (10), p.e74078-e74078

2013

Volltextzugriff (PDF)

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

PloS one, 2013-01, Vol.8 (1), p.e54381-e54381

2013

Volltextzugriff (PDF)

The Short-Term and Long-Term Hazard Ratio Model: Parameterization Inconsistency

The American statistician, 2021-10, Vol.75 (4), p.376-382

2021

Volltextzugriff (PDF)

Accuracy of predictive ability measures for survival models: P. FLANDRE, R. DEUTSCH AND J. O'QUIGLEY

Statistics in medicine, 2017-09, Vol.36 (20), p.3171-3180

2017

Volltextzugriff (PDF)

Comparing Kaplan–Meier curves with delayed treatment effects: applications in immunotherapy trials

Journal of the Royal Statistical Society Series C: Applied Statistics, 2019-08, Vol.68 (4), p.915-939

2019

Volltextzugriff (PDF)

Discussion on "Meta-analysis for surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling"

Biometrics, 2012-03, Vol.68 (1), p.242-245

2012

Volltextzugriff (PDF)

Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

Clinical infectious diseases, 2018, Vol.67 (12), p.1883-1889

2018

Volltextzugriff (PDF)

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Annals of internal medicine, 2011-09, Vol.155 (6), p.402; author reply 403

2011

Volltextzugriff (PDF)

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Annals of internal medicine, 2011-09, Vol.155 (6), p.402

Flandre, Philippe

2011

Volltextzugriff (PDF)

Improved Darunavir Genotypic Mutation Score Predicting Treatment Response for HIV-1 subtype B and non-B Infected Patients Receiving a Salvage Regimen

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (5), p.1352-1360

2016

Volltextzugriff (PDF)

E138K and M1841 mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

AIDS (London), 2012, Vol.26 (13), p.1619-1624

2012

Volltextzugriff (PDF)

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853

2012

Volltextzugriff (PDF)

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm super(3) at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Volltextzugriff (PDF)

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm 3 at the time of diagnosis according to HIV‐1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Volltextzugriff (PDF)

Switching to darunavir/ritonavir 800/100mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

Journal of medical virology, 2013-01, Vol.85 (1), p.8-15

2013

Volltextzugriff (PDF)

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Volltextzugriff (PDF)

Effect of antiretrovirals on semen quality

Journal of medical virology, 2011-06, Vol.83 (8)

2011

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(14)
Human Immunodeficiency Virus
(13)
Hiv
(11)
Science & Technology - Other Topics
(11)
Hiv Infections - Drug Therapy
(10)
Multidisciplinary Sciences
(10)
Antiretroviral Drugs
(8)
Female
(8)
Male
(8)
Virology
(8)
Antiretroviral Agents
(7)
Hiv-1 - Genetics
(7)
Life Sciences
(7)
Mathematics
(7)
Acquired Immune Deficiency Syndrome
(6)
Adult
(6)
Infectious Diseases
(6)
Medicine
(6)
Patients
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Statistical methods in recent HIV noninferiority trials: reanalysis of 11 trials

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study

Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set

A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

The Short-Term and Long-Term Hazard Ratio Model: Parameterization Inconsistency

Accuracy of predictive ability measures for survival models: P. FLANDRE, R. DEUTSCH AND J. O'QUIGLEY

Comparing Kaplan–Meier curves with delayed treatment effects: applications in immunotherapy trials

Discussion on "Meta-analysis for surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling"

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple-integrase inhibitors-based regimen in a French national survey

Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Improved Darunavir Genotypic Mutation Score Predicting Treatment Response for HIV-1 subtype B and non-B Infected Patients Receiving a Salvage Regimen

E138K and M1841 mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm super(3) at the time of diagnosis according to HIV-1 coreceptor tropism

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm 3 at the time of diagnosis according to HIV‐1 coreceptor tropism

Switching to darunavir/ritonavir 800/100mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Effect of antiretrovirals on semen quality

Aktive Filter

Suchergebnisse filtern